Join us throughout AAO Week

Thursday, October 8 I 1:53PM - 1:58PM I Eyecelerator @AAO

Kicking off our week in New Orleans, Carlos Ciller, CEO & Co-founder, presents Transforming Healthcare AI Analytics and Data-Driven Insights (Part of Session: Retina, Biologics, Diagnostics & AI). Don't forget to cast your vote for RetinAI during the People's Choice Award voting at the end of the session!

> Add to your agenda 

‍

Friday, October 9, 2026 | 5:45 PM – 9:00 PM | RetinAI’s Exclusive event at the MISI by Messina’s

From Data to Patients: Accelerating Retina Clinical Trials with AI, Real-World Evidence & Expert Insights, at The MISI by Messina's. Join leading retina specialists Dr. David Eichenbaum, Dr. Michael Javaheri, Dr. Samuel Minaker, and Dr. Deepak Sambhara for an interactive evening on how AI-enabled solutions, large-scale ophthalmic data analysis, and real-world evidence can accelerate clinical development, from patient identification and site selection to disease progression and treatment outcomes. 

Reserve Your Spot Now! - Capacity is limited 

‍

October 10 until October 12 - Visit us at the EssilorLuxottica Booth at AAO (#2719)

RetinAI is featured within the EssilorLuxottica booth #2719 at AAO alongside Heidelberg Engineering, Essilor Instruments, and Espansione Group. See how RetinAI serves as the device-agnostic bridge connecting hardware across device manufacturers to a centralized, AI-powered clinical research and data platform. 

Join us at the booth for presentations and live discussions led by industry leaders.

‍

‍

While you’re here at AAO 

Experience the latest of RetinAI Discovery^®, our modular, cloud-based platform designed to optimize trial feasibility, candidate identification, and clinical research:

• RetinAI Discovery^®(FDA-Cleared): Our device-agnostic platform supporting multimodality image management (OCT, FAF, CFP, DICOM) and collaborative research workflows.
• RetinAI OCT Atlas^®: Comprehensive AI model combining layer and fluid segmentation for high-precision structural disease assessment.
• Discovery CONNECT^®: Automated image upload and synchronization directly from devices like SPECTRALIS^®. Features SMART Search to query patient datasets and identify candidate pools up to 4x larger.
• LuxIA^®: AI-powered screening model for more-than-mild diabetic retinopathy (mtmDR), identifying patients likely to have mtmDR with 97% sensitivity and 95% specificity from color fundus images. 

Book a 1:1 Demo at AAO

‍

Connect with Our Experts

Our scientific, clinical research, and AI development teams will be available at booth #2719 throughout AAO to discuss:

• Candidate Identification & Real World Evidence: Accelerate trial recruitment by 4 to 5 times and automate candidate screening 
• The RetinAI Network of Sites: how US clinical practices and practice networks can monetize data compliantly while participating in top-tier pharma trials.
• Oculomics & Biomarker Research: Explore systemic insights into cardiovascular, metabolic, and neurodegenerative conditions using retinal biomarkers such as RNFL, choroidal thickness, and hyperreflective foci.
• Advanced Imaging Integrations: Experience live demonstrations connecting Heidelberg SPECTRALIS^® OCT imaging with RetinAI's automated AI analytics.

Book a Meeting at Booth #2719